A group of herbalists in Senegal are pushing back against the claims of a US-based company that claims they are better and cheaper than conventional medicines.
The group of about 100 herbalists have formed the Association of Herbal Medicine Professionals (AHMPA) to argue that the herbal medicines in use are far better than the cheaper versions.
The AHMPA says that herbal medicines contain fewer side effects than pharmaceuticals and have been shown to lower the risk of heart attacks, strokes and cancer.
The pharmaceutical companies argue that their products are safe and effective for treating specific conditions.
The AHMAP has said it wants the Government to investigate the claims.
The US company Bayer has called the claim a “misleading and misleading campaign”.
The AHMPA says that the products that are being marketed in Senegal should be tested by the Health Ministry for quality control, and that the AHMPG should monitor their clinical trial results.
The Government of Senegal has also promised to investigate whether the AHMPAP is valid and have promised to take legal action against Bayer.
The companies say that the medicinal products in Senegal have been proven to lower cardiovascular risk factors such as blood pressure, diabetes, heart attacks and cancer, and to reduce the risk for heart attacks.
But the AHAP says the drugs do not have proven health benefits and they are not currently available in Senegal.